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Fusion of a scid Pre-B Cell with a Wild Type (Myeloma)
B Cell Results in Correct Rearrangement of a V(D)J
Recombination Substrate
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Mice with the scid mutation have a defect in the V(D)J recombinase. In order to
determine whether the SCID product is normally present in mature B cells that do not
have the recombinase activity, scid pre-B cells were fused with myeloma cells. It was
found that in the hybrid cells, a rearrangement test gene was correctly joined
immediately after fusion. The same test gene was aberrantly rearranged in the scid pre-B
cells. Stable hybrids between the scid pre-B and the myeloma cells had lost the
expression of RAG-1 and RAG-2 genes, supporting the previous finding of an inhibitor
of rearrangement in myeloma cells that acts shortly after fusion. Thus, mature B cells
apparently contain the SCID product, the wild type SCID function is not competitively
interfered with by products present in scid pre-B cells, and the SCID product seems not
to be a target for the recombinase inhibitor.
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INTRODUCTION
Mice homozygons for the scid mutation do not
produce B or T lymphocytes (Bosma et al., 1983)
because of a defect in V(D)J recombination
(Schuler et al., 1986). Rearrangement of immuno-
globulin (Ig) genes in scid pre-B cells results in
nonfunctional Ig genes due to large deletions
(Hendrickson et al., 1988; Kim et al., 1988; Lieber
et al., 1988; Malynn et al., 1988; Okazaki et al.,
1988; Blackwell et al., 1989; Bosma and Carroll,
1991). The rearrangement defect suggested that
the SCID product may be an essential component
of the V(D)J recombinase. Our studies were
undertaken in order to determine whether
mature wild type B cells express the SCID prod-
uct. We fused scid pre-B cells with mature B
(myeloma) cells and determined the rearrange-
ment status of a test gene that had previously
been stably transfected into the myeloma cells. It
was found that the test gene was rearranged cor-
rectly in the hybrids immediately after fusion.
The same gene was rearran’ged aberrantly in the
scid pre-B cells.
*Corresponding author.
It had been found previously that fusion of
normal pre-B cells with myeloma cells abolishes
the rearrangement activity of the pre-B cells due
to suppression of the expression of the recombi-
nase activating genes RAG-1 and RAG-2 (Engler
et al., 1991b). Thus, mature B cells contain an
inhibitor of the recombinase; Apparently, the
inhibition is at the transcriptional level, because
RAG-1 and RAG-2 genes under the transcrip-
tional control of a ubiquitously expressed
promoter/enhancer combination are expressed
in myeloma cells (J. Zhao, P. Roth, and U. Storb,
unpublished). Thus, during a short time after
fusion before the existing RAG-1 and RAG-2
mRNAs and proteins are degraded, the recombi-
nase is active. We utilized this window to deter-
mine whether normal SCID function was present
in the myeloma cells.
RESULTS
A recombination test gene, pHRD-neo (Fig. 1B),
was transfected into the normal pre-B cells 38B9
and stable transfectants were selected with the
drug G418. As shown in Fig. 2A, all transfectants
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TABLE 1
Summary of Rearrangements
No. of cell clones
without
rearrangement
Rearrangement of pHRD test gene
(RAG expression)
Correct Incorrect
-4.7 bp del 23-37 bp del 0.1-1.8 kb del >1.8 kb del
Scid pre-B cells 6 0 8 18 8
(+) (+) (+) (+)
Scid pre-Bxmyeloma 20 2 0 0 0
(_) (_c)
Myeloma 7 0 0 0 0
(-)
Normal pre-B 0 >8 0 0 0
(+)
aThe number of independent rearrangement events. In parentheses is shown the presence (+) absence (-) of RAG-1 and RAG-2 mRNAs.
bSee text.
CPresumably RAG-1 and RAG-2 only expressed immediately after fusion (see Engler et al., 1991b; and text). The difference in the frequency of correct
rearrangements between the scid pre-B cells (0/34) and the hybrids (2/2) is highly significant, p<-0.002 (Fisher’s Exact Test, Kendall and Stuart, 1973).
del=deletion.
rearrange the pHRD test gene correctly. The
pHRD-neo construct was also transfected into the
scid pre-B cells $33. In this case, stable transfec-
tants expressing the neo gene show aberrant
rearrangements of the pHRD test gene (Fig. 2B).
No correct rearrangement is observed in any .of
the scid pre-B cell transfectants (Fig. 2B; Table 1;
#15 and 19 appear to have a weak band of about
correct size, but see below and Fig. 3B). The
rearrangement substrate is partially unre-
arranged in six of the scid transfectants shown
(#14, 15, 18, 19, 20, and 21). When rearranged, it
shows mostly bands of the wrong size (#14, 15,
16, 20, 22, and 26) or is completely deleted (#17,
23, 24, and 25). All stable transfectants have
retained the neo gene, presumablybecause of the
selection with G418. Thus, deletions larger than
6.6 kb would not be scored, because they would
invade the neo gene. These results confirm pre-
vious findings that this scid pre-B cell has recom-
binase activity, but that its function is defective
(Schuler et al., 1986), because none of the
rearranged genes was correctly rearranged
(Table 1). Presumably, scid pre-B cells produce all
the components required for rearrangement,
except for the SCID product.
To determine whether the wild type SCID
product is active in mature B cells that have lost
the ability for V(D)J rearrangement, we fused $33
cells with the myeloma X63-Ag8.653 (hereafter
referred to as Ag8). The,myeloma cells had been
stably cotransfected with the pHRD test gene and
the neo gene before fusion (Ag8HRD7; Engler et
al., 1991b; see Fig. 1C). The myeloma transfec-
tants Ag8HRD7 had been kept in culture for
months and did not show evidence of rearrange-
ment of the test gene (Fig. 2D). However, two of
the .hybrids between Ag8HRD7 and $33 did
rearrange pHRD, apparently correctly (Fig. 2C).
No rearranged bands of incorrect length were
found after fusion of $33 with Ag8.
In order to determine if indeed fusion with the
myeloma cells had resulted in correcting the scid
rearrangement defect, the VJ joints of the pHRD
test gene in the two scid pre-B x myeloma hybrids
were sequenced. This confirmed that they were
rearranged correctly with small deletions (3 and
5 bp) and the addition of one uncoded nucleotide
(N) (Fig. 3A). Eleven independent DNA clones of
the rearranged pHRD were sequenced from
hybrid #7 and five from hybrid #5 and shown to
be identical.
Some of the joints formed in the scid cells were
also sequenced. We concentrated on those joints
that gave near normal size rearrangement frag-
ments on Southern blots. The smallest deletion
was 23 nucleotides, but most were larger than
100 bp (Fig. 3B and Table 1). In other VJ joints of
the pHRD test gene in wild-type pre-B cells
(Engler and Storb, 1987) and in B and T cells of
transgenic mice (Engler et al., 1991a; and P.
Engler and U.. Storb, unpublished) on average
only 4.72 bp (standard deviation=3.15; standard
error of the mean=0.47) were deleted. Thus, the
joints in the scid pre-B cells are abnormal and the
joints in the scidxmyeloma hybrids are clearly
correct. The repair of the scid defect by factors
present in the myeloma cells appears to beSCID PRODUCT IN MATURE B CELLS 287
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FIGURE 1. Maps of rearrangement substrates. (A) pHRD rearrangement test gene (redrawn after Engler et al., 1991b). The
individual components are mouse Ig heavy-chain enhancer, mouse metallothionein-1 promoter, 7mer-spacer-9mer recombinase
recognition sequences from an Ig Vie region, rat preproinsulin initiation codon and surrounding sequences, 9mer-spacer-7mer
recognition sequences from a Jr region, E. coli xanthine-guanine phosphoribosyl transferase coding sequence, mRNA splicing
and polyadenylation signals from SV40; the pUC13 vector is not shown. Before rearrangement, this plasmid, when digested with
PstI and probed with gpt, results in a 2.6-kb fragment; after rearrangement between the V and recognition sequences, a new PstI
fragment of 3.0 kb is seen (these sizes were measured as 2.5 and 2.7 kb before the gpt sequence was available; Engler and Storb,
1987). (B) pHRD-neo test gene. This plasmid combines the pHRD insert (without pUC) shown in (A) with the neomycin
phosphotransferase gene (modified pko-neo [Van Doren et al., 1984]: pBR322 vector replaced by pBluescript II KS+ [pKS]). (C)
Relationship of the two copies of the rearrangement test gene pHRD and the two copies of the selectable marker gene pko-neo
stably cointegrated in the myeloma Ag8HRD7. The arrows indicate the left-to-right orientation of pHRD (see A) and the 5’ to 3’
direction of the neo genes. Restriction enzymes: E=EcoRI, P=PstI.288 J. ZHAO AND U. STORB
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FIGURE 2. Southern blots of
DNAs from cell lines transfected
with pHRD-ne0. (A) The normal
pre-B cell line 38B9. (B) The scid pre-
B cell line $33. (C) Hybrids between
$33 and the pHRD transfected myel-
oma X63-Ag8.653 (Ag8HRD7;
Engler et al., 1991b). (D) The myel-
oma line Ag8HRD7. (E and F)
Hybrids between $33 and
Ag8HRD7.
(A-D) All DNAs were digested
with PstI and probed with gpt. The g.
blot in (B) was first probed with gpt
and gave the bands shown above
the 2.3-kb marker. The blot was then
reprobed with neo and gave the 900-
bp band (neo) plus some larger
bands not shown here.
(E and F) DNA of hybrid cells (see
C) was digested with EcoRI and
probed with JH3,4 (E) or cut with
BamHI and probed with Ca: (F) to
determine if chromosomes 12 and 6
from both parent cells were present.
The in (B) denotes faint re-
arranged bands representing
rearrangement in only some of the
cells. The bands in #15 and 19
appear of correct size on the Sou-
thern blot, but have large deletions
when sequenced (Fig. 3B). The last
lane on the right in (A), (C), (D), and
penultimate lane in (B) is 38B9
cotransfected with pHRD (Fig. 1A)
and pko-neo. The penultimate lane
in (C) is Ag8HRD7.
un=2.6 kb unrearranged pHRD;
re=3.0 kb correctly rearranged
pHRD. Size markers (,=lambda
phage DNA digested with HindIII)
are shown in right or left lanes.
S33
14 15 16 171819 20 21 2223 2425 26 X
"-- re
-6.6
-4.4
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complete. The difference in rearrangement accu-
racy between $33 and the (Ag8HRD7xS33)
hybrids is statistically highly significant (p<-
0.002).
DISCUSSION
These data show that myeloma cellxscid pre-B
cell hybrids contain the SCID product in a func-SCID PRODUCT IN MATURE B CELLS 289
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pre-B cell line 38B9. (B) The scid pre-
B cell line $33. (C) Hybrids between
$33 and the pHRD transfected myel- r oma X63-Ag8.653 (Ag8HRD7;
Engler et al., 1991b). (D) The myel-
in" un oma line Ag8HRD7. (E and F)
Hybrids between $33 and
Ag8HRD7.
(A-D) All DNAs were digested
with PstI and probed with gpt. The
blot in (B) was first probed with gpt
and gave the bands shown above
the 2.3-kb marker. The blot was then
reprobed with neo and gave the 900-
bp band (neo) plus some larger
bands not shown here.
(E and F) DNA of hybrid cells (see
C) was digested with EcoRI and
probed with JH3,4 (E) or cut with
BamHI and probed with Ca: (F) to
determine if chromosomes 12 and 6
from both parent cells were present.
The in (B) denotes faint
rearranged bands representing
rearrangement in only some of the
cells. The bands in #15 and 19
appear of correct size on the Sou-
thern blot, but have large deletions
when sequenced (Fig. 3B). The last
lane on the right in (A), (C), (D), and
penultimate lane in (B) is 38B9
cotransfected with pHRD (Fig. 1A)
and pko-neo. The penultimate lane
in (C) is Ag8HRD7.
un=2.6 kb unrearranged pHRD;
re=3.0 kb correctly rearranged
pHRD. Size markers (;=lambda
phage DNA dige.sted with HindIII)
are shown in right or left lanes.
tional form that can complement the scid defect.
The SCID product is presumably a
mRNA/protein. The scid pre-B cells may produce
a nonfunctional product that has a lower affinity
for the substrate or for other recombinase com-
ponents and thus does not compete with the
wild-type product in V(D)J recombination.
Alternatively, they may pro.duce no product due
to a nonsense mutation or a large deletion in the
scid locus. The correct rearrangement in $33x
myeloma hybrids suggests that in pre-B cells of
F1 hybrids between scid and normal mice, where
correct Ig gene rearrangement is observed
(Lieber et al., 1988), the pre-B cells are not selec-
ted for suppression of the mutated scid allele.
Most of the scid pre-B cell transfectants show
multiple rearrangements of pHRD, some of
which can be easily scored as different events
because of their different sizes on a Southern blot
(Fig. 2B). Others can be distinguished by DNA
sequencing (Fig. 3B, #20.1 and 20.2). Thus, in the
scid pre-B cells RAG-1 and RAG-2 mRNAs con-290 J. ZHAO AND U. STORB
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B cell line $33. (C) Hybrids between
$33 and the pHRD transfected myel-
oma X63-Ag8.653 (Ag8HRD7;
Engler et al., 1991b). (D) The myel-
oma line Ag8HRD7. (E and F)
Hybrids between $33 and
Ag8HRD7.
(A-D) All DNAs were digested
with PstI and probed with gpt. The
blot in (B) was first probed with gpt
and gave the bands shown above
the 2.3-kb marker. The blot was then
reprobed with neo and gave the 900-
bp band (neo) plus some larger
bands not shown here.
(E and F) DNA of hybrid cells (see
C) was digested with EcoRI and
probed with JH3,4 (E) or cut with
BamHI and probed with Ca: (F) to
determine if chromosomes 12 and 6
from both parent cells were present.
The in (B) denotes faint
rearranged bands representing
rearrangement in only some of the
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appear of correct size on the Sou-
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when sequenced (Fig. 3B). The last
lane on the right in (A), (C), (D), and
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in (C) is Ag8HRD7.
un=2.6 kb unrearranged pHRD;
re=3.0 kb correctly rearranged
pHRD. Size markers (A,=lambda
phage DNA digested with HindIII)
are shown in right or left lanes.
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tinue to be produced and the defective V(D)J
recombinase activity persists.
On the other hand, only 2 of 22 hybrids
between the scid pre-B cells and the myeloma
cells showed evidence of rearrangement of
pHRD (Table 1). This low rate is presumably due
to an inhibitor of rearrangement that we pre-
viously identified in the myeloma cells (Engler et
al., 1991b). When Ag8HRD7 or other Ag8 cells
stably transfected with pHRD are fused with nor-
mal pre-B cells, a few rearrangements also occur
early, but most hybrids also do not rearrange the
test gene (Engler et al., 1991b). In this previous
study, the pre-BxAg8 stable hybrids had lost theSCID PRODUCT IN MATURE B CELLS
unrearranged CAGATCCGTAACAACTTGTAGAGTATCCTCcacagtg
A. AgSHRD7xS33
5 CAGATCCGTAACAACTTGTAGAGTAT T
CAGATCCGTAACAACTTGTAGAGTATC
B. S33pHRD-neo
5.1 CAGATCCGTAACAACTT
7.4 CAGATCCGTAACAACTTGTAG
10.3 CAGATCCGTAACAACTTGT
15.5 CAGATCCGTAACAACTTGT
#19.12 CAGA
20 CAGATCCGTAACAACTTGTAGAGTA G
20 CAGATCCGTAACAACTTGTAGAG
#32.12 CAGATCCG
cactgtgGTGGACGTTCGGTGGAGGCACCAAGCTGGAAATA
291
bp deletion
TGGACGTTCGGTGGAGGCACCAAGCTGGAAATCA
GTGGACGTTCGGTGGAGGCACCAAGCTGGAAATCA
GGTGGAGGCACCAAGCTGGAAATCA 23
GCACCAAGCTGGAAATCA 26
AGGCACCAAGCTGGAAATCA 26
AGCTGGAAATCA 34
GTGGAGGCACCAAGCTGGAAATCA 37
AATCA 35
CACCAAGCTGGAAATCA 25
GTTCGGTGGAGGCGCCAAGCTGGAAATCA 23
FIGURE 3. Sequences of the pHRD rearrangement joints in various cell clones: (A) Ag8xS33 hybrids. (B) $33. For $33, only the
smallest deletions are shown. #20 showed an extremely faint band of nearly correct rearrangement after prolonged exposure of
the Southern blot in Fig. 2B. The top line is the unrearranged sequence, including the recognition sequence 7mers (lower case
letters). The single nucleotides in the center presumably represent N regions. The indicates a changed base (A>G); we have not
determined whether this is a Taq error.
expression of the RAG-1 and RAG-2 genes. Simi-
larly, no RAG-1 or RAG-2 mRNA can be detected
in the scid pre-Bxmyeloma hybrids, whereas the
RAG mRNAs are present in the scid $33 cells
before fusion (Table 1) and proteins encoded by
them presumably cooperate in V(D)J joining reac-
tions immediately after fusion. In hybrids
between scid and normal pre-B cells, RAG-1 and
RAG-2 mRNAs continue to be present (not
shown), suggesting that the fusion event itself is
not responsible for the loss of RAG gene
expression in the S33xAg8 hybrids. Preliminary
results have suggested that the recombinase
inhibitor interferes with transcription of the RAG
genes (J. Zhao, P. Roth, and U. Storb,
unpublished). Thus, early after fusion, the V(D)J
recombinase mRNAs and translated proteins
may act for a period of time defined by their half-
lives. These half-lives have not been determined,
but must be relatively short. Because only one
type of rearranged joint was found in each of the
hybrids (Fig. 3A; 11 and 5 independent DNA
clones, respectively, were found to have the same
VJ-joints) and because the intensities of the
rearranged and unrearranged pHRD bands on
Southern blots are the same (Fig. 2C), it appears
that all cells of one hybrid, clone have the same
one of the two copies of’pHRD rearranged in the
same way. Thus, VJ joining presumably occurred
before the first cell division after cell fusion. This
means that the V(D)J recombinase provided by
the scid pre-B cell and the SCID product provided
by the myeloma cell must have assembled soon
after nuclear fusion on one of the two copies of
pHRD integrated in the Ag8 genome. Further
rearrangements were then apparently prevented
by the action of the inhibitor. It appears unlikely
that the SCID product was induced by the fusion,
because the rearrangement seems to have taken
place immediately after fusion, before the first
cell division. All the Ag8xS33 hybrids have
retained the H- and L-genes from both parent
cells (Figs. 2E and 2F); thus, they are clearly
hybrids. This brings to 39 (22 in this and 17 in the
previous study; Engler et al., 1991b) the Bxpre-B
hybrids that have retained the inhibitor. All of
these have retained the H- and L-genes and thus
chromosomes 12 (D’eustachio et al., 1980) and 6
(Swan et al., 1979) of the Ag8 cell (Figs. 2E and
2F). These Ag8 chromosomes were lost in three
hybrids that had lost the inhibitor and were able
to rearrange Ig test genes (Engler et al., 1991a).
The inhibitor may thus be encoded by genes on
these chromosomes or another chromosome that
happened to be lost at the same time in the
hybrids that continuously produced V(D)J
recombinase (Engler et al., 1991a).
If the inhibitor operates on the transcriptional
level, the expression of its target genes would
continue to be inhibited after fusion. Because292 J. ZHAO AND U. STORB
mature B cells can complement the scid defect
despite the continuous presence of the inhibitor
of rearrangement, apparently the SCID gene or
its product is not a target of the inhibitor.
While this work was in progress, the finding of
a general X-ray hypersensitivity (Fulop and Phil-
lips, 1990; Biederman et al., 1991; Hendrickson et
al., 1991) due to a defect in double-strand DNA
repair in scid fibroblasts was reported. However,
there was some ambiguity as to whether scid
pre-B cells have this defect (Weaver and Hend-
rickson, 1989). The finding of SCID product in
mature B cells that lack the V(D)J recombinase
further supports the idea that the SCID product
may be ubiquitous and that it may function in
both DNA repair and Ig gene rearrangement.
MATERIALS AND METHODS
Cell Lines and Transfection
The scid pre-B cell line $33 (Schuler et al., 1986)
was from M. Bosma (Fox Chase), the normal pre-
B cell line 38B9tk- (Blackwell and Alt, 1984) was
from F. Alt (Harvard University), the myeloma
X63-Ag8.653 (Kearny et al., 1979) was from
J. Kearny (University of Alabama). The 38B9 and
$33 cells were transfected with pHRD-neo (Fig.
1B) by electroporation with 400 volts and 500/F
in a BioRad Gene Pulser in 0.4-cm cuvettes as
described (Engler et al., 1991b). Ag8 cells were
first stably cotransfected with pHRD and pko-
neo (Engler et al., 1991b) (Fig. 1C). They are the
same transfectants shown in Engler et al. (1991b)
named Ag8HRD7. Hybrids between $33 and
Ag8HRD7 were produced by PEG-mediated
fusion and selected in HAT medium (Szybalska
and Szybalski, 1962; Littlefield, 1966) (Ag8 is
HGPRT-minus) and 1 mg/ml G418 (Ag8pHRD7
has the neo gene; see Fig. 1C) in RPMI1640 with
10% fetal bovine serum, beta-mercaptoethanol
and antibiotics.
DNA Amplification by PCR and Sequencing
The DNAs of (S33xAg8HRD) hybrid cells or of
$33 cells with rearranged pHRD bands of nearly
correct size were digested with Pstl to eliminate
the unrearranged DNA and amplified by PCR
using primers PE1 (5’AGACCTCTcTAGAGG-
ATCCCcGGGC3’) and PE2 (5’CCAGTAACGC-
ACCCGGTACCAGACC3’). After electrophoresis
of the PCR product in a 2% agarose gel, a band
corresponding to about 349 bp (which would be
the correctly rearranged size) was isolated. In
case of the hybrids between SCID pre-B cells and
Ag8, the rearranged DNA was directly cloned
into Bluescript IIKS+ (strata-gene) (both the
amplified DNA and the vector were cut with
BamHI/Sstl). In the case of $33, the isolated
rearranged DNA was reamplified by PCR using
primers PE1 and OGPT2 (5’CGCTCATGTG-
AAGTGTCCCAG3’) and the near correctly
rearranged band was isolated from an agarose
gel and cloned as before. The DNAs were
sequenced using the T3 primer of BSK. Some
clones were also sequenced in the other direction
using a metallothionein primer OPmt21
(5’CCTCACTTACTCCGTAGCTCC3’).
Southern Blots and RNA analysis
DNA preparation and Southern (1975) blotting
were as described using probes for gpt or neo
(Engler and Storb, 1987) or Ca: (Selsing and Storb,
1981) or JH3,4 (Manz et al., 1988). RNA was pre-
pared from transfected and fused cells and ana-
lyzed by Northern blots using probes for Rag-1
and Rag-2 (Oettinger et al., 190; Chun et al., 1991)
as described (Engler et al., 1991b).
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